VIKING GLOBAL INVESTORS LP - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 192 filers reported holding EDITAS MEDICINE INC in Q2 2019. The put-call ratio across all filers is 3.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
VIKING GLOBAL INVESTORS LP ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q2 2020$12,217,000
+20.3%
413,000
-19.4%
0.05%0.0%
Q1 2020$10,157,000
-53.2%
512,179
-30.2%
0.05%
-48.0%
Q4 2019$21,716,000
+30.2%
733,4010.0%0.10%
+17.2%
Q3 2019$16,678,000
-27.6%
733,401
-21.3%
0.09%
-15.5%
Q2 2019$23,043,000
+1.2%
931,4010.0%0.10%
-21.4%
Q1 2019$22,773,000
+7.5%
931,4010.0%0.13%
+8.3%
Q4 2018$21,189,000
-28.5%
931,4010.0%0.12%
-26.2%
Q3 2018$29,637,000
-11.2%
931,4010.0%0.16%
-14.1%
Q2 2018$33,372,000
-2.8%
931,401
-10.0%
0.19%
-7.7%
Q1 2018$34,320,000
-34.7%
1,035,304
-39.4%
0.21%
-35.9%
Q4 2017$52,530,000
+28.0%
1,709,4010.0%0.32%
+21.4%
Q3 2017$41,043,000
+43.1%
1,709,4010.0%0.27%
+37.8%
Q2 2017$28,684,000
-24.8%
1,709,4010.0%0.19%
+14.2%
Q1 2017$38,154,000
+37.5%
1,709,4010.0%0.17%
+34.1%
Q4 2016$27,744,000
+20.4%
1,709,4010.0%0.13%
+27.3%
Q3 2016$23,043,000
-44.8%
1,709,4010.0%0.10%
-44.1%
Q2 2016$41,709,000
-43.5%
1,709,401
-20.0%
0.18%
-45.5%
Q1 2016$73,761,0002,135,5230.32%
Other shareholders
EDITAS MEDICINE INC shareholders Q2 2019
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders